{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:58:12Z","timestamp":1775869092695,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Lundbeck GmbH, Hamburg, Germany","award":["2007- 006914- 41"],"award-info":[{"award-number":["2007- 006914- 41"]}]},{"DOI":"10.13039\/501100001661","name":"Ruprecht-Karls-Universit\u00e4t Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There exists little empirical evidence helping clinicians to select the most effective treatment for individual patients with persistent depressive disorder (PDD). This study identifies and characterizes subgroups of patients with PDD who are likely to benefit more from an acute treatment with psychotherapy than from pharmacotherapy and vice versa. Non-medicated outpatients with PDD were randomized to eight weeks of acute treatment with the Cognitive Behavioral Analysis System of Psychotherapy (CBASP; n\u2009=\u200929) or escitalopram plus clinical management (ESC\/CM; n\u2009=\u200931). We combined several baseline variables to one composite moderator and identified two subgroups of patients: for 56.0%, ESC\/CM was associated with a greater reduction in depression severity than CBASP, for the remaining 44.0%, it was the other way around. Patients likely to benefit more from ESC\/CM were more often female, had higher rates of moderate-to-severe childhood trauma, more adverse life events and more previous suicide attempts. Patients likely to benefit more from CBASP were older, had more often an early illness onset and more previous treatments with antidepressants. Symptomatic response, remission, and reductions in symptom severity occurred more often in those patients treated with their likely more effective treatment condition. The findings suggest that the baseline phenotype of patients with PDD moderates their benefit from acute treatment with CBASP relative to ESC\/CM. Once confirmed in an independent sample, these results could serve to guide the choice between primarily psychotherapeutic or pharmacological treatments for outpatients with PDD.<\/jats:p>","DOI":"10.1007\/s00406-023-01672-0","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T07:02:12Z","timestamp":1692687732000},"page":"723-737","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identifying subgroups with differential response to CBASP versus Escitalopram during the first eight weeks of treatment in outpatients with persistent depressive disorder"],"prefix":"10.1007","volume":"274","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9811-1360","authenticated-orcid":false,"given":"Ilinca","family":"Serbanescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Knut","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Zobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Drost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Fangmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Normann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Schoepf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"key":"1672_CR1","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/jclp.10181","volume":"59","author":"BA Arnow","year":"2003","unstructured":"Arnow BA, Constantino MJ (2003) Effectiveness of psychotherapy and combination treatment for chronic depression. J Clin Psychol 59:893\u2013905. https:\/\/doi.org\/10.1002\/jclp.10181","journal-title":"J Clin Psychol"},{"key":"1672_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jad.2012.01.033","volume":"139","author":"JA Murphy","year":"2012","unstructured":"Murphy JA, Byrne GJ (2012) Prevalence and correlates of the proposed DSM-5 diagnosis of Chronic Depressive Disorder. J Affect Disord 139:172\u2013180. https:\/\/doi.org\/10.1016\/j.jad.2012.01.033","journal-title":"J Affect Disord"},{"key":"1672_CR3","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th ed","DOI":"10.1176\/appi.books.9780890425596"},{"key":"1672_CR4","volume-title":"Treatment for chronic depression: cognitive behavioral analysis system of psychotherapy","author":"JP McCullough","year":"2000","unstructured":"McCullough JP (2000) Treatment for chronic depression: cognitive behavioral analysis system of psychotherapy. Guilford Press, New York, NY"},{"key":"1672_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.eurpsy.2015.12.003","volume":"33","author":"A Jobst","year":"2016","unstructured":"Jobst A, Brakemeier E-L, Buchheim A et al (2016) European psychiatric association guidance on psychotherapy in chronic depression across Europe. Eur Psychiatry 33:18\u201336. https:\/\/doi.org\/10.1016\/j.eurpsy.2015.12.003","journal-title":"Eur Psychiatry"},{"key":"1672_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/archpsyc.62.5.513","volume":"62","author":"AF Schatzberg","year":"2005","unstructured":"Schatzberg AF, Rush AJ, Arnow BA et al (2005) Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Arch Gen Psychiatry 62:513\u2013520. https:\/\/doi.org\/10.1001\/archpsyc.62.5.513","journal-title":"Arch Gen Psychiatry"},{"key":"1672_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.4088\/jcp.08m04371","volume":"70","author":"JH Kocsis","year":"2009","unstructured":"Kocsis JH, Leon AC, Markowitz JC et al (2009) Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis aystem of psychotherapy, or their combination. J Clin Psychiatry 70:354\u2013361. https:\/\/doi.org\/10.4088\/jcp.08m04371","journal-title":"J Clin Psychiatry"},{"key":"1672_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000489227","volume":"87","author":"TA Furukawa","year":"2018","unstructured":"Furukawa TA, Efthimiou O, Weitz ES et al (2018) Cognitive-behavioral analysis system of psychotherapy, drug, or their combination for persistent depressive disorder: personalizing the treatment choice using individual participant data network metaregression. Psychother Psychosom 87:140\u2013153. https:\/\/doi.org\/10.1159\/000489227","journal-title":"Psychother Psychosom"},{"key":"1672_CR9","doi-asserted-by":"publisher","first-page":"103512","DOI":"10.1016\/j.brat.2019.103512","volume":"124","author":"I Serbanescu","year":"2020","unstructured":"Serbanescu I, Walter H, Schnell K et al (2020) Combining baseline characteristics to disentangle response differences to disorder-specific versus supportive psychotherapy in patients with persistent depressive disorder. Behav Res Ther 124:103512. https:\/\/doi.org\/10.1016\/j.brat.2019.103512","journal-title":"Behav Res Ther"},{"key":"1672_CR10","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/jclp.10180","volume":"59","author":"JH Kocsis","year":"2003","unstructured":"Kocsis JH (2003) Pharmacotherapy for chronic depression. J Clin Psychol 59:885\u2013892. https:\/\/doi.org\/10.1002\/jclp.10180","journal-title":"J Clin Psychol"},{"key":"1672_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cpr.2009.09.003","volume":"30","author":"P Cuijpers","year":"2010","unstructured":"Cuijpers P, van Straten A, Schuurmans J et al (2010) Psychotherapy for chronic major depression and dysthymia: a meta-analysis. Clin Psychol Rev 30:51\u201362. https:\/\/doi.org\/10.1016\/j.cpr.2009.09.003","journal-title":"Clin Psychol Rev"},{"key":"1672_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1146\/annurev-clinpsy-050817-084746","volume":"14","author":"ZD Cohen","year":"2018","unstructured":"Cohen ZD, DeRubeis RJ (2018) Treatment selection in depression. Annu Rev Clin Psychol 14:209\u2013236","journal-title":"Annu Rev Clin Psychol"},{"key":"1672_CR13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1001\/jamapsychiatry.2016.4070","volume":"74","author":"P Cuijpers","year":"2017","unstructured":"Cuijpers P, Huibers MJH, Furukawa TA (2017) The need for research on treatments of chronic depression. JAMA Psychiat 74:242\u2013243. https:\/\/doi.org\/10.1001\/jamapsychiatry.2016.4070","journal-title":"JAMA Psychiat"},{"key":"1672_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S2215-0366(20)30099-7","volume":"7","author":"E Schramm","year":"2020","unstructured":"Schramm E, Klein DN, Elsaesser M et al (2020) Review of dysthymia and persistent depressive disorder: history, correlates, and clinical implications. The Lancet Psychiatry 7:801\u2013812. https:\/\/doi.org\/10.1016\/S2215-0366(20)30099-7","journal-title":"The Lancet Psychiatry"},{"key":"1672_CR15","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1176\/appi.ajp.2010.09111680","volume":"167","author":"GE Simon","year":"2010","unstructured":"Simon GE, Perlis RH (2010) Personalized medicine for depression: can we match patients with treatments? Am J Psychiatry 167:1445\u20131455. https:\/\/doi.org\/10.1176\/appi.ajp.2010.09111680","journal-title":"Am J Psychiatry"},{"key":"1672_CR16","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1001\/jamapsychiatry.2013.1960","volume":"70","author":"ML Wallace","year":"2013","unstructured":"Wallace ML, Frank E, Kraemer HC (2013) A novel approach for developing and interpreting treatment moderator profiles in randomized clinical trials. JAMA Psychiat 70:1241\u20131247. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.1960","journal-title":"JAMA Psychiat"},{"key":"1672_CR17","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/cpp.2081","volume":"24","author":"P Bausch","year":"2017","unstructured":"Bausch P, Fangmeier T, Zobel I et al (2017) The impact of childhood maltreatment on the differential efficacy of CBASP versus escitalopram in patients with chronic depression: a secondary analysis. Clin Psychol Psychother 24:1155\u20131162. https:\/\/doi.org\/10.1002\/cpp.2081","journal-title":"Clin Psychol Psychother"},{"key":"1672_CR18","doi-asserted-by":"publisher","first-page":"14293","DOI":"10.1073\/pnas.2336126100","volume":"100","author":"CB Nemeroff","year":"2003","unstructured":"Nemeroff CB, Heim CM, Thase ME et al (2003) Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci 100:14293\u201314296. https:\/\/doi.org\/10.1073\/pnas.2336126100","journal-title":"Proc Natl Acad Sci"},{"key":"1672_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jpsychires.2012.09.018","volume":"47","author":"SA Shankman","year":"2013","unstructured":"Shankman SA, Campbell ML, Klein DN et al (2013) Dysfunctional attitudes as a moderator of pharmacotherapy and psychotherapy for chronic depression. J Psychiatr Res 47:113\u2013121. https:\/\/doi.org\/10.1016\/j.jpsychires.2012.09.018","journal-title":"J Psychiatr Res"},{"key":"1672_CR20","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/da.21977","volume":"29","author":"D Steidtmann","year":"2012","unstructured":"Steidtmann D, Manber R, Arnow BA et al (2012) Patient treatment preference as a predictor of response and attrition in treatment for chronic depression. Depress Anxiety 29:896\u2013905. https:\/\/doi.org\/10.1002\/da.21977","journal-title":"Depress Anxiety"},{"key":"1672_CR21","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.biopsych.2005.09.014","volume":"59","author":"HC Kraemer","year":"2006","unstructured":"Kraemer HC, Kupfer DJ (2006) Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry 59:990\u2013996. https:\/\/doi.org\/10.1016\/j.biopsych.2005.09.014","journal-title":"Biol Psychiatry"},{"key":"1672_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000381957","volume":"84","author":"E Schramm","year":"2015","unstructured":"Schramm E, Zobel I, Schoepf D et al (2015) Cognitive behavioral analysis system of psychotherapy versus escitalopram in chronic major depression. Psychother Psychosom 84:227\u2013240. https:\/\/doi.org\/10.1159\/000381957","journal-title":"Psychother Psychosom"},{"key":"1672_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-31066-4","volume-title":"Treating chronic depression with disciplined personal involvement: cognitive behavioral analysis system of psychotherapy (CBASP)","author":"JP McCullough","year":"2006","unstructured":"McCullough JP (2006) Treating chronic depression with disciplined personal involvement: cognitive behavioral analysis system of psychotherapy (CBASP). Springer, New York, NY"},{"key":"1672_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006532.pub2","author":"A Cipriani","year":"2009","unstructured":"Cipriani A, Santilli C, Furukawa TA et al (2009) Escitalopram versus other antidepressive agents for depression. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD006532.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1672_CR25","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1002\/sim.5734","volume":"32","author":"HC Kraemer","year":"2013","unstructured":"Kraemer HC (2013) Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach. Stat Med 32:1964\u20131973. https:\/\/doi.org\/10.1002\/sim.5734","journal-title":"Stat Med"},{"key":"1672_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jpsychires.2016.07.005","volume":"81","author":"SF Smagula","year":"2016","unstructured":"Smagula SF, Wallace ML, Anderson SJ et al (2016) Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder. J Psychiatr Res 81:112\u2013118. https:\/\/doi.org\/10.1016\/j.jpsychires.2016.07.005","journal-title":"J Psychiatr Res"},{"key":"1672_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.brat.2016.12.012","volume":"90","author":"ML Wallace","year":"2017","unstructured":"Wallace ML, McMakin DL, Tan PZ et al (2017) The role of day-to-day emotions, sleep, and social interactions in pediatric anxiety treatment. Behav Res Ther 90:87\u201395. https:\/\/doi.org\/10.1016\/j.brat.2016.12.012","journal-title":"Behav Res Ther"},{"key":"1672_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","volume":"70","author":"RL Wasserstein","year":"2016","unstructured":"Wasserstein RL, Lazar NA (2016) The ASA statement on p-values: context, process, and purpose. Am Stat 70:129\u2013133. https:\/\/doi.org\/10.1080\/00031305.2016.1154108","journal-title":"Am Stat"},{"key":"1672_CR29","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.neuroimage.2018.07.051","volume":"181","author":"ML Wallace","year":"2018","unstructured":"Wallace ML, Banihashemi L, O\u2019Donnell C et al (2018) Using optimal combined moderators to define heterogeneity in neural responses to randomized conditions: Application to the effect of sleep loss on fear learning. Neuroimage 181:718\u2013727. https:\/\/doi.org\/10.1016\/j.neuroimage.2018.07.051","journal-title":"Neuroimage"},{"key":"1672_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R (1996) Regression shrinkage and selection via the lasso. J R Stat Soc Ser B 58:267\u2013288. https:\/\/doi.org\/10.1111\/j.2517-6161.1996.tb02080.x","journal-title":"J R Stat Soc Ser B"},{"key":"1672_CR31","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.beth.2017.02.001","volume":"48","author":"AN Niles","year":"2017","unstructured":"Niles AN, Loerinc AG, Krull JL et al (2017) Advancing personalized medicine: application of a novel statistical method to identify treatment moderators in the coordinated anxiety learning and management study. Behav Ther 48:490\u2013500. https:\/\/doi.org\/10.1016\/j.beth.2017.02.001","journal-title":"Behav Ther"},{"key":"1672_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brat.2017.01.001","volume":"91","author":"AN Niles","year":"2017","unstructured":"Niles AN, Wolitzky-Taylor KB, Arch JJ, Craske MG (2017) Applying a novel statistical method to advance the personalized treatment of anxiety disorders: a composite moderator of comparative drop-out from CBT and ACT. Behav Res Ther 91:13\u201323. https:\/\/doi.org\/10.1016\/j.brat.2017.01.001","journal-title":"Behav Res Ther"},{"key":"1672_CR33","volume-title":"An introduction to statistical learning with applications in R","author":"G James","year":"2013","unstructured":"James G, Witten D, Hastie T, Tibshirani R (2013) An introduction to statistical learning with applications in R. Springer, New York, NY"},{"key":"1672_CR34","doi-asserted-by":"publisher","unstructured":"Ahrens A, Hansen CB, Schaffer ME (2019) lassopack: model selection and prediction with regularized regression in Stata. arXiv Prepr arXiv190105397. https:\/\/doi.org\/10.1177\/1536867X2090","DOI":"10.1177\/1536867X2090"},{"key":"1672_CR35","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1177\/070674371305800703","volume":"58","author":"J Spijker","year":"2013","unstructured":"Spijker J, van Straten A, Bockting CLH et al (2013) Psychotherapy, antidepressants, and their combination for chronic major depressive disorder: a systematic review. Can J Psychiatry 58:386\u2013392. https:\/\/doi.org\/10.1177\/070674371305800703","journal-title":"Can J Psychiatry"},{"key":"1672_CR36","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.psychres.2017.06.082","volume":"256","author":"C Zatti","year":"2017","unstructured":"Zatti C, Rosa V, Barros A et al (2017) Childhood trauma and suicide attempt: a meta-analysis of longitudinal studies from the last decade. Psychiatry Res 256:353\u2013358. https:\/\/doi.org\/10.1016\/j.psychres.2017.06.082","journal-title":"Psychiatry Res"},{"key":"1672_CR37","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.psychres.2016.11.002","volume":"246","author":"D de Mattos","year":"2016","unstructured":"de Mattos D, Souza L, Lopez Molina M, Azevedo da Silva R, Jansen K (2016) History of childhood trauma as risk factors to suicide risk in major depression. Psychiatry Res 246:612\u2013616. https:\/\/doi.org\/10.1016\/j.psychres.2016.11.002","journal-title":"Psychiatry Res"},{"key":"1672_CR38","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1600-0447.2005.00647.x","volume":"112","author":"A Roy","year":"2005","unstructured":"Roy A, Janal M (2005) Family history of suicide, female sex, and childhood trauma: separate or interacting risk factors for attempts at suicide? Acta Psychiatr Scand 112:367\u2013371. https:\/\/doi.org\/10.1111\/j.1600-0447.2005.00647.x","journal-title":"Acta Psychiatr Scand"},{"key":"1672_CR39","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/da.20243","volume":"24","author":"M Sarchiapone","year":"2007","unstructured":"Sarchiapone M, Carli V, Cuomo C, Roy A (2007) Childhood trauma and suicide attempts in patients with unipolar depression. Depress Anxiety 24:268\u2013272. https:\/\/doi.org\/10.1002\/da.20243","journal-title":"Depress Anxiety"},{"key":"1672_CR40","doi-asserted-by":"publisher","first-page":"609954","DOI":"10.3389\/fpsyt.2020.609954","volume":"11","author":"JP McCullough","year":"2021","unstructured":"McCullough JP (2021) Characteristics of the optimal cognitive behavioral analysis system of psychotherapy (CBASP) therapist role. Front Psychiatry 11:609954. https:\/\/doi.org\/10.3389\/fpsyt.2020.609954","journal-title":"Front Psychiatry"},{"key":"1672_CR41","doi-asserted-by":"publisher","unstructured":"Schoepf D (2013) CBASP with intensified significant other history exercise for chronic major depression with antecedent dysthymic disorder in outpatient treatment: Rationale, assessment and effects on the hypothesized core content of the patient\u2019s in-session interpersonal fear. Psychiatric Disorders-New Frontiers in Affective Disorders. IntechOpen, 153\u2013182. https:\/\/doi.org\/10.5772\/51638","DOI":"10.5772\/51638"},{"key":"1672_CR42","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/S2215-0366(22)00227-9","volume":"9","author":"E Kuzminskaite","year":"2022","unstructured":"Kuzminskaite E, Gathier AW, Cuijpers P et al (2022) Treatment efficacy and effectiveness in adults with major depressive disorder and childhood trauma history: a systematic review and meta-analysis. The Lancet Psychiatry 9:860\u2013873. https:\/\/doi.org\/10.1016\/S2215-0366(22)00227-9","journal-title":"The Lancet Psychiatry"},{"key":"1672_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1037\/1053-0479.13.3-4.241","volume":"13","author":"JP McCullough","year":"2003","unstructured":"McCullough JP (2003) Treatment for chronic depression: cognitive behavioral analysis system of psychotherapy (CBASP). J Psychother Integr 13:241\u2013263. https:\/\/doi.org\/10.1037\/1053-0479.13.3-4.241","journal-title":"J Psychother Integr"},{"key":"1672_CR44","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.biopsych.2013.03.021","volume":"74","author":"JM Miller","year":"2013","unstructured":"Miller JM, Hesselgrave N, Ogden RT et al (2013) Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder. Biol Psychiatry 74:760\u2013767. https:\/\/doi.org\/10.1016\/j.biopsych.2013.03.021","journal-title":"Biol Psychiatry"},{"key":"1672_CR45","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/s41380-019-0377-5","volume":"24","author":"KC Vadodaria","year":"2019","unstructured":"Vadodaria KC, Ji Y, Skime M et al (2019) Altered serotonergic circuitry in SSRI-resistant major depressive disorder patient-derived neurons. Mol Psychiatry 24:808\u2013818. https:\/\/doi.org\/10.1038\/s41380-019-0377-5","journal-title":"Mol Psychiatry"},{"key":"1672_CR46","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1016\/j.neubiorev.2012.12.007","volume":"37","author":"P Willner","year":"2013","unstructured":"Willner P, Scheel-Kr\u00fcger J, Belzung C (2013) The neurobiology of depression and antidepressant action. Neurosci Biobehav Rev 37:2331\u20132371. https:\/\/doi.org\/10.1016\/j.neubiorev.2012.12.007","journal-title":"Neurosci Biobehav Rev"},{"key":"1672_CR47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0145-2134(02)00541-0","volume":"27","author":"DP Bernstein","year":"2003","unstructured":"Bernstein DP, Stein JA, Newcomb MD et al (2003) Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl 27:169\u2013190. https:\/\/doi.org\/10.1016\/S0145-2134(02)00541-0","journal-title":"Child Abuse Negl"},{"key":"1672_CR48","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382\u2013389. https:\/\/doi.org\/10.1192\/bjp.134.4.382","journal-title":"Br J Psychiatry"},{"key":"1672_CR49","volume-title":"Structured clinical interview for DSM-IV-TR axis I disorders, research version, clinical trials version (SCID-CT)","author":"M First","year":"2002","unstructured":"First M, Spitzer R, Gibbon M, Williams J (2002) Structured clinical interview for DSM-IV-TR axis I disorders, research version, clinical trials version (SCID-CT). Biometrics Research, New York"},{"key":"1672_CR50","volume-title":"Structured clinical interview for DSM-IV axis II personality disorders (SCID-II)","author":"M First","year":"1997","unstructured":"First M, Gibbon M, Spitzer R, Williams J (1997) Structured clinical interview for DSM-IV axis II personality disorders (SCID-II). American Psychiatric Press, Washington, DC"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-023-01672-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-023-01672-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-023-01672-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T12:05:44Z","timestamp":1712232344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-023-01672-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1672"],"URL":"https:\/\/doi.org\/10.1007\/s00406-023-01672-0","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,22]]},"assertion":[{"value":"2 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare to take full responsibility for the integrity of the data and accuracy of the data analysis. All authors can provide full access to all the data in this study. Dr. Schoepf received honoraria for workshops and presentations relating to CBASP. Dr. Schramm received modest book royalties and honoraria for workshops and presentations relating to CBASP. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committee on human experimentation with the Helsinki Declaration of 1975, as revised in 2008.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}